Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE

被引：0
|
作者：
Javian C. Malcolm
Nadia Falzone
Jennifer E. Gains
Matthew D. Aldridge
David Mirando
Boon Q. Lee
Mark N. Gaze
Katherine A. Vallis
机构：
[1] University of Oxford,Oxford Institute for Radiation Oncology
[2] University College London Hospitals NHS Foundation Trust,Department of Oncology
[3] University College London Hospitals NHS Foundation Trust,Institute of Nuclear Medicine
[4] MIM Software,undefined
来源：
EJNMMI Physics | / 9卷
关键词：
[; Lu]Lu-DOTATATE; Dosimetry; Inter-cyclic changes; Pharmacokinetics; Peptide receptor radionuclide therapy; Neuroblastoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE
    Malcolm, Javian C.
    Falzone, Nadia
    Gains, Jennifer E.
    Aldridge, Matthew D.
    Mirando, David
    Lee, Boon Q.
    Gaze, Mark N.
    Vallis, Katherine A.
    EJNMMI PHYSICS, 2022, 9 (01)
  • [2] p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
    Hanna Berglund
    Sara Lundsten Salomonsson
    Tabassom Mohajershojai
    Fernando Jose Ferrer Gago
    David P. Lane
    Marika Nestor
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 768 - 778
  • [3] p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
    Berglund, Hanna
    Salomonsson, Sara Lundsten
    Mohajershojai, Tabassom
    Gago, Fernando Jose Ferrer
    Lane, David P.
    Nestor, Marika
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (03) : 768 - 778
  • [4] Growth hormone and TSH deficiency after [177Lu] Lu-DOTATATE therapy for pediatric neuroblastoma; description of a first case
    van Wessel, Karen
    de Keizer, Bart
    Dierselhuis, Miranda
    van Santen, Hanneke
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 120 - 120
  • [5] Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [ 177 Lu]Lu-DOTATATE
    Warfvinge, Carl Fredrik
    Gustafsson, Johan
    Roth, Daniel
    Tennvall, Jan
    Svensson, Johanna
    Bernhardt, Peter
    Akesson, Anna
    Wieslander, Elinore
    Sundlov, Anna
    Gleisner, Katarina Sjogreen
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (07) : 1070 - 1075
  • [6] Effects of adding an albumin binder chain on [177Lu]Lu-DOTATATE
    Rousseau, Etienne
    Lau, Joseph
    Zhang, Zhengxing
    Uribe, Carlos F.
    Kuo, Hsiou-Ting
    Zhang, Chengcheng
    Zeisler, Jutta
    Colpo, Nadine
    Lin, Kuo-Shyan
    Benard, Francois
    NUCLEAR MEDICINE AND BIOLOGY, 2018, 66 : 10 - 17
  • [7] Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) 177Lu
    Nanabala, Raviteja
    Pillai, Maroor Raghavan Ambikalmajan
    Gopal, Buvaneswari
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 56 (06) : 313 - 322
  • [8] Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) 177Lu
    Raviteja Nanabala
    Maroor Raghavan Ambikalmajan Pillai
    Buvaneswari Gopal
    Nuclear Medicine and Molecular Imaging, 2022, 56 : 313 - 322
  • [9] Bone marrow absorbed doses during treatment with [177Lu]Lu-DOTATATE assuming a specific uptake in the red marrow
    Hagmarker, L.
    Svensson, J.
    Ryden, T.
    Van Essen, M.
    Sundlov, A.
    Gjertsson, P.
    Gleisner, K. Sjogreen
    Bernhardt, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S30 - S30
  • [10] Prognostic value of inflammation biomarkers for survival in patients with neuroendocrine tumors treated with [177Lu]Lu-DOTATATE
    Pineiro, A.
    Trivino Ibanez, E.
    Villa Palacios, J.
    Muros de Fuentes, M.
    Sanchez Sanchez, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S247 - S247
12345